Tanaka C, Kato R (eds).

[New Pharmacology (4th ed)] (In Japanese)

Nankodo (2002)

Wlodawer A, Vondrasek J.

Inhibitors of HIV-1 protease: a major success of structure-assisted drug design.

Annu Rev Biophys Biomol Struct 27:249-84 (1998)
DOI:10.1146/annurev.biophys.27.1.249

Brik A, Wong CH.

HIV-1 protease: mechanism and drug discovery.

Org Biomol Chem 1:5-14 (2003)
DOI:10.1039/b208248a

Wynn GH, Zapor MJ, Smith BH, Wortmann G, Oesterheld JR, Armstrong SC, Cozza KL.

Antiretrovirals, part 1: overview, history, and focus on protease inhibitors.

Psychosomatics 45:262-70 (2004)
DOI:10.1176/appi.psy.45.3.262

Sugiura W.

[Progress in antiretroviral drugs]

Uirusu 55:85-94 (2005)
DOI:10.2222/jsv.55.85

Mimoto T, Imai J, Tanaka S, Hattori N, Kisanuki S, Akaji K, Kiso Y.

KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic.

Chem Pharm Bull (Tokyo) 39:3088-90 (1991)
DOI:10.1248/cpb.39.3088